CAS
952308-04-2 Purity
---
952308-04-2 Purity
---
Shopping basket
2-Methylindazole-5-Boronic Acid
CAS
952319-71-0
Catalog Number
ACM952319710
Category
Other Products
Molecular Formula
C8H9N2O2B
If you have any other questions or need other size, please get a quote.
- Product Description
- Case Study
- Custom Reviews
- Custom Q&A
- Synthetic Use
- Related Resources
Specification
Synonyms
2-METHYLINDAZOLE-5-BORONICACID
What is the molecular formula of 2-Methylindazole-5-Boronic Acid?
The molecular formula of 2-Methylindazole-5-Boronic Acid is C8H9BN2O2.
When was 2-Methylindazole-5-Boronic Acid created and last modified?
2-Methylindazole-5-Boronic Acid was created on July 21, 2009, and last modified on December 30, 2023.
What is the IUPAC name of 2-Methylindazole-5-Boronic Acid?
The IUPAC name of 2-Methylindazole-5-Boronic Acid is (2-methylindazol-5-yl)boronic acid.
What is the InChIKey of 2-Methylindazole-5-Boronic Acid?
The InChIKey of 2-Methylindazole-5-Boronic Acid is KVNWFZDGOYSXJG-UHFFFAOYSA-N.
What is the molecular weight of 2-Methylindazole-5-Boronic Acid?
The molecular weight of 2-Methylindazole-5-Boronic Acid is 175.98 g/mol.
How many hydrogen bond donor counts does 2-Methylindazole-5-Boronic Acid have?
2-Methylindazole-5-Boronic Acid has 2 hydrogen bond donor counts.
How many hydrogen bond acceptor counts does 2-Methylindazole-5-Boronic Acid have?
2-Methylindazole-5-Boronic Acid has 3 hydrogen bond acceptor counts.
What is the exact mass of 2-Methylindazole-5-Boronic Acid?
The exact mass of 2-Methylindazole-5-Boronic Acid is 176.0757077 g/mol.
How many heavy atoms are present in 2-Methylindazole-5-Boronic Acid?
2-Methylindazole-5-Boronic Acid has 13 heavy atoms.
Is 2-Methylindazole-5-Boronic Acid the canonicalized compound?
Yes, 2-Methylindazole-5-Boronic Acid is the canonicalized compound.
Downstream Synthesis Route 1
- 1914946-33-0
- 952319-71-0
- 2410540-88-2
Reference: [1]Current Patent Assignee: MERCK & CO INC - WO2020/28150, 2020, A1
Location in patent: Page/Page column 52; 53
Downstream Synthesis Route 2
- 952319-71-0
- 1159511-41-7
Reference: [1]Current Patent Assignee: TERNS PHARMACEUTICALS INC - WO2021/41237, 2021, A1
Location in patent: Paragraph 0196
* For details of the synthesis route, please refer to the original source to ensure accuracy.
Please kindly note that our products are for research use only.
Recommended Products
